Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis.
about
Linking Medicare, Medicaid, and cancer registry data to study the burden of cancers in West Virginia.Clinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective study.Hospital-based health care use correlates with incidence of adverse events among elderly Medicare patients treated in adjuvant chemotherapy trials (Alliance 70802).Retrospective comparative study of the effects of dendritic cell vaccine and cytokine-induced killer cell immunotherapy with that of chemotherapy alone and in combination for colorectal cancer.Estimating the treatment effect from non-randomized studies: The example of reduced intensity conditioning allogeneic stem cell transplantation in hematological diseases.Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans treated in the community.Molecular mechanism of adenomatous polyposis coli-induced blockade of base excision repair pathway in colorectal carcinogenesis.Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy.Determinants of adjuvant oxaliplatin receipt among older stage II and III colorectal cancer patients.Comparative effectiveness of postoperative chemotherapy among older patients with non-metastatic rectal cancer treated with preoperative chemoradiotherapy.Effectiveness of adjuvant chemotherapy for elderly patients with lymph node-positive colorectal cancer.Validity of the Danish National Registry of Patients for chemotherapy reporting among colorectal cancer patients is highA Systematic Review of Emergency Department Use Among Cancer PatientsTreatment of older patients with colorectal cancer: a perspective review.Building personalized treatment plans for early-stage colorectal cancer patients.Comparative Toxicity and Effectiveness of Trastuzumab-Based Chemotherapy Regimens in Older Women With Early-Stage Breast Cancer.Magnetic nanoparticle hyperthermia induced cytosine deaminase expression in microencapsulated E. coli for enzyme-prodrug therapy.Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study.Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colorectal cancer: the ACCORE study.The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program.
P2860
Q30814844-13114D3C-A0FD-4EE5-9096-869C9A689992Q33427019-A3697E28-DA05-487C-A747-F1F5CA2FFDD7Q33992552-E1FE28F2-BDA8-4081-BD07-76DC13AD0CBBQ34119366-8652DF55-419B-4732-A24C-BE69DAB36E89Q34382106-46FB42FD-0DFB-4ABB-B2FC-2F59E129A067Q34734413-1C8C6C45-E029-4623-BD0C-3A33B9BC1CAEQ36159222-1C0365CD-31C8-49F1-AF4C-38D349853676Q36859634-A5D01B93-7AAC-4BF0-B2F3-F2F4F50F984AQ36874822-0AA47402-B509-4904-909E-A0CDE6568D3FQ36913615-2B0A9459-B2B6-4206-825F-C9D3E44B2ED6Q37133361-280D2A34-0F26-4172-BFFC-07449B12B326Q37164131-367FF315-2D28-4F0B-83AA-BC97807B1944Q37211576-4FDB1252-E3C6-491A-B2DD-B55B9C995209Q37704350-CEDBE703-0B7B-4D37-81B7-0BF54430B0BDQ37706705-452E11A7-5E56-4376-87CB-82CB107BBFF1Q38670254-F78D28F6-9F1D-446B-8B08-AC2545043C84Q38893603-5C836857-AF8F-4A43-A72F-50837372B0B6Q42706819-9AE0DCF0-90FD-46FA-A275-0B694E711877Q54878242-2903A385-8163-4388-B799-EC06161C3B1FQ55005151-158FB5AF-6742-40FF-BEC8-932AE5DFA03C
P2860
Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Comparison of adverse events d ...... : a population-based analysis.
@ast
Comparison of adverse events d ...... : a population-based analysis.
@en
type
label
Comparison of adverse events d ...... : a population-based analysis.
@ast
Comparison of adverse events d ...... : a population-based analysis.
@en
prefLabel
Comparison of adverse events d ...... : a population-based analysis.
@ast
Comparison of adverse events d ...... : a population-based analysis.
@en
P2093
P2860
P356
P1433
P1476
Comparison of adverse events d ...... r: a population-based analysis
@en
P2093
Deborah Schrag
Hanna K Sanoff
Janet Freburger
Maria J Schymura
Richard M Goldberg
William R Carpenter
P2860
P304
P356
10.1002/CNCR.27422
P407
P577
2012-01-31T00:00:00Z